InVivo announces Platinum sponsorship to W2W spinal cord injury symposium

InVivo Therapeutics (OTC/BB: NVIV) today announced the Company's Platinum level sponsorship of the 6^th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.

Working 2 Walk (W2W) is an annual event held by Unite 2 Fight Paralysis to bring together spinal cord injury research scientists, practitioners, investors and consumers for a lively discussion of current research and strategies that will accelerate progress toward cures for paralysis. Unite 2 Fight Paralysis is a not-for-profit organization dedicated to the realization of curative therapies.

"We are thrilled to be a part of this important event and to have the opportunity to provide Platinum Sponsorship for such an essential networking of peers," expressed Frank Reynolds, CEO of InVivo Therapeutics. "It is our hope that this scientific meeting will drive awareness of the therapies being developed, including those from InVivo, with the goal of treating and preventing paralysis from spinal cord injuries."

InVivo Therapeutics has submitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) for permission to begin human pilot studies with the Company's proprietary biopolymer scaffold implant for the treatment of spinal cord injuries. The majority of patients with paralysis become paralyzed in the period after the initial injury due to bleeding and inflammation at the lesion site. These secondary injuries can occur for up to three weeks following the initial trauma. The scaffold is implanted into the injured spinal cord where it biodegrades at a controlled rate over approximately 12 weeks with the goal of preventing this secondary injury.

Frank Reynolds and InVivo's Medical Director, Jonathan Slotkin, M.D. will be speaking at the symposium regarding the use of the injectable hydrogel the Company is developing as a minimally invasive option to deliver agents locally in chronic and acute spinal cord injuries.